As of 14 Oct 2026, OrganOx has raised $142M across 1 verified round on record; latest: USD 142 million venture – Series Unknown round led by HealthQuest Capital, announced 27 Feb 2025.
OrganOx advances liver transplantation with normothermic perfusion to extend preservation and improve patient outcomes.
1 source
No additional investors or headquarters are stated.
Published by hand (dealmatrix.com): "OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital": biggest-rounds completeness (K): hand-checked, the cited page states USD 142 million
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Venture – Series Unknown [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $142M | 2025-02-27 | HealthQuest Capital | No recent discussion |
1 source [ VERIFIED ] read against 1 source No additional investors or headquarters are stated. Published by hand (dealmatrix.com): "OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital": biggest-rounds completeness (K): hand-checked, the cited page states USD 142 million | ||||